In the News
July 17, 2019
The Pink Sheet | Comparative Confusion: What Does FDA Intend for Opioid Comparative Efficacy Data?
Marc Scheineson comments on the U.S. Food and Drug Administration’s recent draft guidance on the benefit and risk assessment for opioids.
Media Contact